Marion Merrell Dow: Difference between revisions
rd --> Merrell Dow Pharmaceuticals (for now) |
Americasroof (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Infobox Defunct Company |
|||
#REDIRECT [[Merrell Dow Pharmaceuticals]] |
|||
| company_name = Marion Merrell Dow |
|||
{{R with possibilities}} |
|||
| company_logo = |
|||
| slogan = |
|||
| fate = Acquired by [[Hoeschst AG]] |
|||
| successor = Hoechst Marion Roussel |
|||
| foundation = 1950 (Marion Laboratories)<br>1989 (Marion Merrell Dow) |
|||
| defunct = 1996 |
|||
| location = [[Kansas City, Missouri]] |
|||
| industry = [[Pharmaceutical]] |
|||
| key_people = |
|||
| products = |
|||
| num_employees = <!--peak number of employees--> |
|||
| parent = <!--former parent companies, if any--> |
|||
| subsid = <!--former subsidiaries, if any--> |
|||
}} |
|||
'''Marion Merrell Dow''' and its predecessor '''Marion Laboratories''' was a pharmecuteical company based in [[Kansas City, Missouri]] from 1950 until 1996. |
|||
The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including [[Cardizem]] (which slowed [[calcium]] build up), [[Carafate]] (an [[ulcer]] treatment), [[Gaviscon]] (an antacid), [[Seldane]] (Histamine antagonist|antihistamine]]), [[Nicorette]] (anti-smoking gum) and [[Cepacol]] mouthwash. |
|||
The company operating out of its headquarters at 9300 Ward Parkway was a springboard for its founder [[Ewing Marion Kauffman]] to start the [[Kansas City Royals]] baseball team. |
|||
==History== |
|||
===Marion Laboratories=== |
|||
Kauffman, a former pharmaceutical salesman in [[Decatur, Illinois]] started the company in the basement of his Kansas City home by selling calcium supplements made from crushed [[oyster]] shells which he made in his home and starting with $4,000 in capital. Kaufmann would say later he used his middle name for the company to avoid the impression that it was a one-person operation. |
|||
The company quickly took off. As Kauffman expanded he offered his employees [[share options]] and [[profit sharing]]. |
|||
Rather researching products, the company adopted a policy of buy products discovered by other companies and reformulating them for market. |
|||
In 1964 it formally incorporated at Marion Laboratories, Inc. |
|||
In the 1980s it marketed [[Sivadone]] (a burn cream), [[Ditropan]] (treatment for [[bladder infections]]), [[Nito-Bid]] ([[chest pain]] treatment), [[Ard]] and [[Bac-T-Screen]] (helped identify bacteria), [[Culturette]] (used to to identify Group A [[streptococci]]) and ToxiLab, a drug detection system used to detect [[drug abuse]]. |
|||
===Marion Merrell Dow=== |
|||
In 1989 Merrell Dow, a subdivision of [[Dow Chemical]] acquired 67 percent interest and the company was renamed Marion Merrell Dow. Among the products Merrell Dow brought that would be shortly marked were Seldane, Lorelco, Nicorette and Cepacol. The merger was considered a good fit because of Marion Laboratories strong sales force and Merrell Dow's strong research and develop capabilities. |
|||
The new company traded on the [[New York Stock Exchange]] under the [[ticker symbol]] "MKC." |
|||
===Hoechst Marion Roussel=== |
|||
In 1995 [[Hoechst AG]] of Germany announced plans to buy Dow's increased 71 percent share for $25.75 a share or $7.1 Billion -- a profit of between $4 and $5 billion for Dow. Hoeschst also bought the other outstanding shares.<ref>[http://findarticles.com/p/articles/mi_qa3653/is_199505/ai_n8732298 Hoechst agrees to acquire Marion Merrell Dow - Corporate Growth Weekly - May 15, 1995]</ref> |
|||
Hoescht's new pharaceutical company became Hoechst Marion Roussel. Hoescht in turn would become [[Sanofi-Aventis]]. |
|||
Revision as of 17:23, 24 August 2008
| Industry | Pharmaceutical |
|---|---|
| Founded | 1950 (Marion Laboratories) 1989 (Marion Merrell Dow) |
| Defunct | 1996 |
| Fate | Acquired by Hoeschst AG |
| Successor | Hoechst Marion Roussel |
| Headquarters | Kansas City, Missouri |
Marion Merrell Dow and its predecessor Marion Laboratories was a pharmecuteical company based in Kansas City, Missouri from 1950 until 1996.
The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including Cardizem (which slowed calcium build up), Carafate (an ulcer treatment), Gaviscon (an antacid), Seldane (Histamine antagonist|antihistamine]]), Nicorette (anti-smoking gum) and Cepacol mouthwash.
The company operating out of its headquarters at 9300 Ward Parkway was a springboard for its founder Ewing Marion Kauffman to start the Kansas City Royals baseball team.
History
Marion Laboratories
Kauffman, a former pharmaceutical salesman in Decatur, Illinois started the company in the basement of his Kansas City home by selling calcium supplements made from crushed oyster shells which he made in his home and starting with $4,000 in capital. Kaufmann would say later he used his middle name for the company to avoid the impression that it was a one-person operation.
The company quickly took off. As Kauffman expanded he offered his employees share options and profit sharing.
Rather researching products, the company adopted a policy of buy products discovered by other companies and reformulating them for market.
In 1964 it formally incorporated at Marion Laboratories, Inc.
In the 1980s it marketed Sivadone (a burn cream), Ditropan (treatment for bladder infections), Nito-Bid (chest pain treatment), Ard and Bac-T-Screen (helped identify bacteria), Culturette (used to to identify Group A streptococci) and ToxiLab, a drug detection system used to detect drug abuse.
Marion Merrell Dow
In 1989 Merrell Dow, a subdivision of Dow Chemical acquired 67 percent interest and the company was renamed Marion Merrell Dow. Among the products Merrell Dow brought that would be shortly marked were Seldane, Lorelco, Nicorette and Cepacol. The merger was considered a good fit because of Marion Laboratories strong sales force and Merrell Dow's strong research and develop capabilities.
The new company traded on the New York Stock Exchange under the ticker symbol "MKC."
Hoechst Marion Roussel
In 1995 Hoechst AG of Germany announced plans to buy Dow's increased 71 percent share for $25.75 a share or $7.1 Billion -- a profit of between $4 and $5 billion for Dow. Hoeschst also bought the other outstanding shares.[1]
Hoescht's new pharaceutical company became Hoechst Marion Roussel. Hoescht in turn would become Sanofi-Aventis.